4Cheng JQ, Jiang X, Fraser M, et al. Role of X-linked inhibitor of apoptosis protein in chem. oresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway [ J ]. Drug Resist Updat, 2002, 5 (3-4) : 131-146.
5Ahmed N, Pansino F, Clyde R, et al. Overexpression of αv136 integrin in serous epithelial ovariancancer regulates extracellular matrix degradation via the plasminogen activation cascade [ J ]. Carcinogenesis, 2002,23 ( 2 ) :237-244.
6Wang R, Ghahary A, Shen Q, et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor beta1 mRNA and protein than normal skin and cells [ J ]. Wound Repair Regen, 2000,8(2) :128-137.
7FUNAKI N O, TANAKA J, OHSHIO G, et al. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinima patients[J]. Br J Cancer, 1998,77:1327.
8BURCHILL S A, BRADBURG M F, PITTMAN K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction[J]. Br J Can cer, 1995,71:278.
9ADELSMARR M A, MCCARTHY J B, SHIMIZUR Y, et al. Stimulation of betal-integrin function by epidermal growth factor and heregulirrbeta has distinct requirements for erbB2 but a similar dependence on phosphoinositide a-OH kinase[J]. Mol Biol Cell, 1999,10 :2861-2878.
10MARTINY-BARON G, MARME D. VEGF-mediated tumor angiogenesis:a new target for cancer therapy[J]. Curr Opin Biotechnol, 1995,6(6) : 675.
